Evidence map›Paper›PMID 42412842›Full record

ArticleBioinformatics (Oxford, England)2026

PU-GRAIL: residue-level graph learning for identifying protective bacterial antigens under positive-unlabeled supervision.

Jaemin Jeon, Sangwook Jung, Inuk Jung, Kwangsoo Kim, Jinki Yeom

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jaemin JeonInterdisciplinary Program in Bioinformatics, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0009-0006-7922-1034
Sangwook JungDepartment of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Inuk JungSchool of Computer Science and Engineering, Kyungpook National University, Daegu 41566, Republic of Korea.ORCID 0000-0003-0675-4244
Kwangsoo KimDepartment of Medicine, Seoul National University, Seoul 03080, Republic of Korea.ORCID 0000-0002-4586-5062
Jinki YeomInterdisciplinary Program in Bioinformatics, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0002-5332-2658

Funding

Korea Health Industry Development Institute HI23C026400Korea Health Industry Development Institute RS-2023-00304637Korea Health Technology R&DKorea National Institute of Health 2024-ER-0801-01National Research Foundation of Korea RS-2024-00414964National Research Foundation of Korea Basic Science Research Programs 2020M3A9H5104237National Research Foundation of Korea Basic Science Research Programs 2020R1A5A1019023National Research Foundation of Korea Basic Science Research Programs 2021R1C1C1005184
6 · The paper itself

Abstract

motivationThe identification of protective antigens is fundamentally constrained by sparse annotations and pervasive label uncertainty in reverse vaccinology. Protective antigen-antibody interactions are mediated by a limited subset of surface-accessible residues that form spatially coherent epitopes. This motivates modeling antigenicity at the residue level, where 3D structure provides critical context for functional immune recognition. Moreover, antigen datasets are inherently positive unlabeled: unannotated proteins may contain hidden positives, making reliable negatives difficult to obtain.

resultsWe present PU-GRAIL, a graph neural network framework that integrates protein language model embeddings with predicted 3D structures under positive-unlabeled learning. Trained and evaluated on three benchmark datasets, PU-GRAIL achieves competitive performance compared with existing methods. Importantly, the model's attention mechanism enables residue-level interpretation, identifying putative epitope regions that correspond to experimentally validated antibody-binding sites. Beyond standard benchmarks, we demonstrate practical utility through (i) severity-associated antigenicity patterns in SARS-CoV-2 patient cohorts, and (ii) proteome-wide vaccine candidate prioritization across 11 bacterial species. AVAILABILITY AND IMPLEMENTATION: The PU-GRAIL software is available at https://github.com/jaeminjj/PU-GRAIL.

Indexed as

Antigens, BacterialComputational BiologyEpitopesGraph Neural NetworksHumansReverse VaccinologySARS-CoV-2SoftwareAntigens, BacterialEpitopes

Identifiers

PMID42412842
PMCPMC13341136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.